Overexpression of CDCP1 is Associated with Poor Prognosis and Enhanced Immune Checkpoints Expressions in Breast Cancer

Table 2

Univariate and multivariate analysis of survival in patients with BrCa.

Clinic-pathologicalcharacteristics	Univariate analysis			Multivariate analysis
	HR	95%CI	Value	HR	95%CI	Value
Age	1.21	0.64–2.29	0.559
Grade	1.33	0.66–2.68	0.429
T stage	1.54	0.86–2.78	0.149
N stage	1.36	0.98–1.90	0.067
TNM stage	2.13	1.19–3.84	0.011	2.90	1.51–5.56	0.001
ER status	0.43	0.22–0.80	0.008	3.19	0.51–20.07	0.217
PR status	0.34	0.18–0.67	0.002	0.55	0.19–1.57	0.260
HER2 status	1.04	0.49–2.19	0.924
Molecular type	1.84	1.30–2.60	0.001	2.38	0.92–6.17	0.075
CDCP1 expression	2.10	1.08–4.06	0.028	2.13	1.04–4.34	0.038